Announcements

On Behalf of IDSA: Urge Lawmakers to Protect PEPFAR Funding

MAY-22-13 IDSA is asking for you to join them and lend your name to a letter in support of PEPFAR funding for the next fiscal year. Click here to read the letter and sign by Monday, June 3-Noon Eastern time.

Renewal of the National Viral Hepatitis Action Plan, 2014-2016

MAY-20-13 Dr. Ronald Valdiserri writes to recognize the second anniversary of Combating the Silent Epidemic of Viral Hepatitis: Action Plan for the Prevention, Care & Treatment of Viral Hepatitis and to share an important announcement from Dr. Howard Koh about plans to update and renew the existing plan through 2014-2016.

HIV Forum congrulates Nina Mani on her new position at FDA

MAY-17-13 Please join the Forum in congratulating Nina Mani on an exciting new career move. Nina is leaving the Forum, but she is not going far – starting June 3 she will join the FDA Center for Drug Evaluation Research, Division of Antiviral Products. That we will miss her is the understatement of the century. But the offer to join our colleagues at the FDA as a project manager presented a phenomenal opportunity – an excellent fit for her career path. We congratulate Jeff, Kim, Jules and Patrick on an excellent choice! We imagine that many of you will have the pleasure of interacting with her in her new capacity.

National Viral Hepatitis Action Plan to Be Renewed

MAY-16-13 Dr. Howard Koh, the Assistant Secretary for Health, announced on May 16 that the partner agencies are committed and dedicated to renewing the Action Plan for another three years and are currently working on their vision and priorities for 2014-2016.

HIV Forum Mourns the Passing of Executive Committee Member Dr. Jim Goodrich

MAY-10-13 We are saddened to report the death of James Goodrich, PhD, MD of ViiV Healthcare, a member of the Forum’s Executive Committee. Jim passed away unexpectedly last weekend and is survived by his wife, Carolyn and two teenage daughters. A memorial service for Jim will be held this summer on a date to be determined. Jim has been a considered and thoughtful participant on the Executive Committee. His desire to improve care for patients, direct approach and sense of humor will be missed. Please join us in keeping Jim’s family in our thoughts and prayers.

Upcoming Events

29-Jun-13

IAS 2013 Towards an HIV Cure Symposium

14-Jun-13

FDA Public Meeting on HIV Patient-Focused Drug Development and HIV Cure Research

04-Jun-13

International Workshop on HIV & Hepatitis Virus Drug Resistance and Curative Strategies

23-May-13

Hepatitis B and C Testing and Awareness Day in House of Representatives

Join Our Email Service

HIV/TB Co-Infection

Materials and Links

HIV and TB in the context of universal access: what is working and what is not?

Meeting Report

Presentations from the session at the 3rd IAS Conference on HIV Pathogenesis and Treatment

Paul Nunn
Anne Goldfeld
Richard Chaisson
Renee Ridzon

Roundtable Discussion Presentations

Roundtable Introduction
Summary
Wafaa El-Sa

Background:

The World Health Organization, UNAIDS, International AIDS Society , Treatment Action Group and Forum for Collaborative HIV Research are jointly organizing a one and half day international pre-conference consultative meeting entitled HIV and TB in the context of universal access: what is working and what is not? on behalf of the Global TB/HIV Working Group of the Stop TB Partnership in conjunction with XVI International AIDS Conference in Toronto, Canada.

Status

The meeting on HIV and TB in the context of universal access: what is working and what is not? was held on August 12-13, 2006 at Holiday Inn on King Hotel in Toronto, Canada.

The session on HIV/TB Co-Infection: New Visions, New Directions was held on July 25th, 2005 during the 3rd IAS Conference on HIV Pathogenesis and Treatment in Rio de Janeiro. The Roundtable Discussion was also held on July 25th, 2005.

Scientific Steering Committee:

Francoise Barre-Sinoussi, Institut Pasteur & ANRS
Anne Goldfeld, Harvard & Cambodia Health Committee
Mark Harrington, Treatment Action Group
Diane Havlie, UC San Francisco
Barbara Laughon, NIAID/NIH
Karen Manson, Tibotec
Craig McClure, International AIDS Society
Veronica Miller, Forum for Collaborative HIV Research
Paul Nunn, WHO-StopTB
Renee Ridzon, Bill & Melinda Gates Foundation
Mel Spigelman, The Global Alliance for TB Drug Development

In This Section